The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt

(2015) Andromachi Karachaliou et al.   CLINICAL INFECTIOUS DISEASES

From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project

(2015) M. Teresa Aguado et al.   CLINICAL INFECTIOUS DISEASES

The Evolution of the Meningitis Vaccine Project

(2015) Kathleen Tiffay et al.   CLINICAL INFECTIOUS DISEASES

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013

(2015) Clément Lingani et al.   CLINICAL INFECTIOUS DISEASES

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine

(2015)   JOURNAL OF INFECTIOUS DISEASES

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso—Implications for introduction of PsA-TT into the Expanded Programme on Immunization

(2015) Sarah A. Meyer et al.   VACCINE

Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria

(2014) Matthew J. Ferrari et al.   International Health

Global practices of meningococcal vaccine use and impact on invasive disease

(2014) Asad Ali et al.   Pathogens and Global Health

Spatio-Temporal Factors Associated with Meningococcal Meningitis Annual Incidence at the Health Centre Level in Niger, 2004–2010

(2014) Juliette Paireau et al.   PLoS Neglected Tropical Diseases

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

(2013) DM Daugla et al.   LANCET

Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

(2013) Sara Tartof et al.   PLoS One

Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact

(2013) Hannah Christensen et al.   VACCINE

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

(2013) Don Husereau et al.   VALUE IN HEALTH

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

(2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant   CLINICAL INFECTIOUS DISEASES

Effect of vaccines on bacterial meningitis worldwide

(2012) Peter B McIntyre et al.   LANCET

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

(2012) Ryan T Novak et al.   LANCET INFECTIOUS DISEASES

Can we defeat meningococcal disease in low and middle income countries?

(2012) Brian Greenwood et al.   VACCINE

Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience

(2012) Mamoudou H. Djingarey et al.   VACCINE

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt

(2012) Brian Greenwood   VACCINE

Modelling meningococcal meningitis in the African meningitis belt

(2011) T. J. IRVING et al.   EPIDEMIOLOGY AND INFECTION

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: A persistent problem with an imminent solution

(2009) F. Marc LaForce et al.   VACCINE

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults

(2009) Richarda M. de Voer et al.   VACCINE